Literature DB >> 23802178

Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Joshua J Ziarek1, Anthony E Getschman, Stephen J Butler, Deni Taleski, Bryan Stephens, Irina Kufareva, Tracy M Handel, Richard J Payne, Brian F Volkman.   

Abstract

Tyrosine sulfation is a post-translational modification that enhances protein-protein interactions and may identify druggable sites in the extracellular space. The G protein-coupled receptor CXCR4 is a prototypical example with three potential sulfation sites at positions 7, 12, and 21. Each receptor sulfotyrosine participates in specific contacts with its chemokine ligand in the structure of a soluble, dimeric CXCL12:CXCR4(1-38) complex, but their relative importance for CXCR4 binding and activation by the monomeric chemokine remains undefined. NMR titrations with short sulfopeptides showed that the tyrosine motifs of CXCR4 varied widely in their contributions to CXCL12 binding affinity and site specificity. Whereas the Tyr21 sulfopeptide bound the same site as in previously solved structures, the Tyr7 and Tyr12 sulfopeptides interacted nonspecifically. Surprisingly, the unsulfated Tyr7 peptide occupied a hydrophobic site on the CXCL12 monomer that is inaccessible in the CXCL12 dimer. Functional analysis of CXCR4 mutants validated the relative importance of individual CXCR4 sulfotyrosine modifications (Tyr21 > Tyr12 > Tyr7) for CXCL12 binding and receptor activation. Biophysical measurements also revealed a cooperative relationship between sulfopeptide binding at the Tyr21 site and CXCL12 dimerization, the first example of allosteric behavior in a chemokine. Future ligands that occupy the sTyr21 recognition site may act as both competitive inhibitors of receptor binding and allosteric modulators of chemokine function. Together, our data suggests that sulfation does not ubiquitously enhance complex affinity and that distinct patterns of tyrosine sulfation could encode oligomer selectivity, implying another layer of regulation for chemokine signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23802178      PMCID: PMC3783652          DOI: 10.1021/cb400274z

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  51 in total

1.  Characterization of tyrosine sulphation in rFVIII (turoctocog alfa) expressed in CHO and HEK-293 cells.

Authors:  P F Nielsen; S Bak; B Vandahl
Journal:  Haemophilia       Date:  2012-06-11       Impact factor: 4.287

Review 2.  The SH2 domain: versatile signaling module and pharmaceutical target.

Authors:  Kazuya Machida; Bruce J Mayer
Journal:  Biochim Biophys Acta       Date:  2004-11-19

3.  Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Thomas P Sakmar; Brian F Volkman
Journal:  J Mol Biol       Date:  2006-05-11       Impact factor: 5.469

4.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.

Authors:  Q Ma; D Jones; P R Borghesani; R A Segal; T Nagasawa; T Kishimoto; R T Bronson; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

5.  Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).

Authors:  Joshua H Y Tan; Meritxell Canals; Justin P Ludeman; Jamie Wedderburn; Christopher Boston; Stephen J Butler; Ann Marie Carrick; Todd R Parody; Deni Taleski; Arthur Christopoulos; Richard J Payne; Martin J Stone
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

6.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

7.  Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.

Authors:  Frederic Sierro; Christine Biben; Laura Martínez-Muñoz; Mario Mellado; Richard M Ransohoff; Meizhang Li; Blanche Woehl; Helen Leung; Joanna Groom; Marcel Batten; Richard P Harvey; Carlos Martínez-A; Charles R Mackay; Fabienne Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

8.  Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).

Authors:  Joshua H Y Tan; Justin P Ludeman; Jamie Wedderburn; Meritxell Canals; Pam Hall; Stephen J Butler; Deni Taleski; Arthur Christopoulos; Michael J Hickey; Richard J Payne; Martin J Stone
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

9.  Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction.

Authors:  Joshua J Ziarek; Yan Liu; Emmanuel Smith; Guolin Zhang; Francis C Peterson; Jun Chen; Yongping Yu; Yu Chen; Brian F Volkman; Rongshi Li
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

10.  Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.

Authors:  Lewis R Vidler; Nathan Brown; Stefan Knapp; Swen Hoelder
Journal:  J Med Chem       Date:  2012-07-12       Impact factor: 7.446

View more
  25 in total

1.  Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.

Authors:  Ishan Roy; Donna M McAllister; Egal Gorse; Kate Dixon; Clinton T Piper; Noah P Zimmerman; Anthony E Getschman; Susan Tsai; Dannielle D Engle; Douglas B Evans; Brian F Volkman; Balaraman Kalyanaraman; Michael B Dwinell
Journal:  Cancer Res       Date:  2015-09-01       Impact factor: 12.701

2.  Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment.

Authors:  Federica De Leo; Giacomo Quilici; Mario Tirone; Francesco De Marchis; Valeria Mannella; Chiara Zucchelli; Alessandro Preti; Alessandro Gori; Maura Casalgrandi; Rosanna Mezzapelle; Marco E Bianchi; Giovanna Musco
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

3.  Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Authors:  Bryan S Stephens; Tony Ngo; Irina Kufareva; Tracy M Handel
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 8.192

4.  Chemokine cooperativity is caused by competitive glycosaminoglycan binding.

Authors:  Guido J R Zaman; Martine J Smit; Folkert Verkaar; Jody van Offenbeek; Miranda M C van der Lee; Lambertus H C J van Lith; Anne O Watts; Angelique L W M M Rops; David C Aguilar; Joshua J Ziarek; Johan van der Vlag; Tracy M Handel; Brian F Volkman; Amanda E I Proudfoot; Henry F Vischer
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

5.  Structure-Based Identification of Novel Ligands Targeting Multiple Sites within a Chemokine-G-Protein-Coupled-Receptor Interface.

Authors:  Emmanuel W Smith; Amanda M Nevins; Zhen Qiao; Yan Liu; Anthony E Getschman; Sai L Vankayala; M Trent Kemp; Francis C Peterson; Rongshi Li; Brian F Volkman; Yu Chen
Journal:  J Med Chem       Date:  2016-04-14       Impact factor: 7.446

Review 6.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

7.  Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.

Authors:  Christoph Seibert; Anthony Sanfiz; Thomas P Sakmar; Christopher T Veldkamp
Journal:  Methods Enzymol       Date:  2015-11-14       Impact factor: 1.600

8.  The free energy landscape in translational science: how can somatic mutations result in constitutive oncogenic activation?

Authors:  Chung-Jung Tsai; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2014-01-21       Impact factor: 3.676

Review 9.  What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?

Authors:  Irina Kufareva; Martin Gustavsson; Yi Zheng; Bryan S Stephens; Tracy M Handel
Journal:  Annu Rev Biophys       Date:  2017-05-22       Impact factor: 12.981

10.  The Solution Structure of CCL28 Reveals Structural Lability that Does Not Constrain Antifungal Activity.

Authors:  Monica A Thomas; Jie He; Francis C Peterson; Anna R Huppler; Brian F Volkman
Journal:  J Mol Biol       Date:  2018-06-15       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.